58 filings
Page 3 of 3
8-K
q3usqg68n4ka2 ndkt7k
17 Mar 21
Axcella Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
7:44am
8-K
nqk36mf1h7jkh35ct96
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
m77kl6wxy zs2kx
12 Nov 20
Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
7:47am
8-K
m87 wqlmb34xs8
31 Aug 20
Entry into a Material Definitive Agreement
9:00am
8-K
5gmv5gsn m06b7d
5 Aug 20
Axcella Reports Positive Top-Line Data from AXA1665-002 and Second Quarter Financial Results
8:22am
8-K
4juyv nw6lsk1ungwxzb
20 May 20
Departure of Directors or Certain Officers
4:05pm
8-K
5huw7fm1uvu09wqsu
18 May 20
Axcella Announces Pricing of Public Offering of Common Stock
4:17pm
8-K
94tzclnl1clz9lx
11 May 20
Axcella Reports First Quarter Financial Results and Provides Business Update
8:13am
8-K
hgsg uy037uvx
8 May 20
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
3fw9ugegz0uj9m4
6 May 20
Axcella Announces Positive Top-Line Data from AXA1125-003 Clinical Study Showing Multifactorial Activity in Adult Subjects with NAFLD
8:09am
8-K
2jgj0v8cydtp4
23 Mar 20
Axcella Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:03pm
8-K
bt9tpj27de7xne
25 Nov 19
Axcella Strengthens Executive Team with Key Addition and Promotion
8:11am
8-K
gvm3gen7j ixnc
12 Nov 19
Results of Operations and Financial Condition
4:04pm
8-K
xdhxhlt2b ebvx
8 Nov 19
Departure of Directors or Certain Officers
4:08pm
8-K
yu5ymgzya2yf
23 Aug 19
Entry into a Material Definitive Agreement
4:18pm
8-K
0nku5ajqen0mbi0v1
12 Aug 19
Results of Operations and Financial Condition
4:50pm
8-K
wru xpaw9z
20 Jun 19
Results of Operations and Financial Condition
4:44pm
8-K
99a exuzp
17 May 19
Amendments to Articles of Incorporation or Bylaws
4:07pm